European ombudsman Nikiforos Diamandouros has called on the European Medicines Agency (EMA) to grant access to clinical study reports and trial protocols for anti-obesity drugs. His demand follows a complaint from Danish healthcare researchers who wanted to conduct an independent analysis of the drugs. In 2007, the researchers, from a health and information centre, asked to see clinical study reports and corresponding trial protocols for two anti-obesity drugs. They explained that they wanted to conduct an independent analysis given that, in their view, biased reporting on drug trials was common.
Read article at theparliament.com
Friday, June 18, 2010
European Medicines Agency told to provide details on anti-obesity drugs
Posted by
Willow
at
3:18 pm
Labels: anti-obesity drug, drug trials, European Medicines Agency
Tuesday, August 25, 2009
Concerns that OTC anti-obesity drug, orlistat, brand name Alli, may cause liver damage.
Reported here: BBC News item.
Extracts from the report:
"The FDA said the most commonly reported adverse reactions included the yellowing of skin or whites of the eyes, weakness and stomach pain.
Between 1999 and 2008, the agency received 32 reports of liver damage, 30 of which occurred outside the US. Of these 27 resulted in hospitalisation.
The agency said it was now conducting a review of the safety of the drug, but stressed no definite association with liver damage had been established at this stage."
"In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said it had received a total of 1,295 suspected adverse drug reaction reports associated with orlistat, including 137 involving suspected liver damage, since it was licensed in 1998."
There is no need to take drugs, risking adverse side-effects, to lose weight. You can lose weight fast, easily and safely by cutting down on salt and salty food.
Lose weight, reduce your risk of most cancers, high blood pressure, type 2 diabetes, heart disease, heart attack, vascular dementia, stroke, osteopenia, osteoporosis, hypercholesterolaemia, depression, liver damage and kidney problems, and improve your health in many other ways without drugs, hunger or expense by eating less salt! - Try it! - You will feel so much better! See my website www.wildeaboutsteroids.co.uk
The site does not sell anything and has no banners or sponsors or adverts - just helpful information.
Read my Mensa article on Obesity and the Salt Connection
Sodium in foods and
http://www.wildeaboutsteroids.co.uk/story.html - my 'political' page
See advice for pregnant mothers
and FAT RETENTIONhttp://www.wildeaboutsteroids.co.uk/socio.html - social and economic considerations
I can be contacted from my website if you need my further help. My help is free.
Posted by
Willow
at
8:16 pm
Labels: adverse side-effects, Alli, anti-obesity drug, drug safety, eat less salt and salty food, FDA, GlaxoSmithKline, liver damage, Lose weight safely, MHRA, orlistat
Friday, October 31, 2008
The European drugs watchdog is recommending doctors do not prescribe the anti-obesity drug rimonabant, also known as Acomplia.
The European drugs watchdog is recommending doctors do not prescribe the anti-obesity drug rimonabant, also known as Acomplia. The European Medicines Agency has said the risk of serious psychiatric problems and even suicide are too high.
Read article on the BBC News website (UK)
Posted by
Willow
at
12:02 pm
Labels: Acomplia, adverse side-effects, anti-obesity drug, rimonabant, suicide

